Construct · 1 fields · 1 citations

drug-target residence time: a standalone construct

One name. One construct. A landmark on the map.

● anchor · a standalone construct Nearest construct by meaning·not indexed
drug-targetresidence time1 CONSTRUCTDrug-target residenceCOPELAND · PHARMACOLOGY

A single standalone construct; nearby constructs are located against it in the Collider. Tap a field for its definition, unit, and measures.

Pharmacology

how long a drug stays bound to its target, argued to predict in vivo effect better than binding affinity.

In pharmacology, drug-target residence time refers to how long a drug stays bound to its target, argued to predict in vivo effect better than binding affinity. This meaning comes from Copeland (2006) in Nature Reviews Drug Discovery.[1]

Unit
Recovery means
Measured by

Next

Run it through the Collider, or take the citations with you.

See how drug-target residence time sits against neighbouring constructs in the Collider, or export every reference on this page in one click.

Open in ColliderExport BibTeXReport this entry

Nearby constructs

affinity3 fields · 4 citationsjingle · one word, three constructsbinding4 fields · 4 citationsjingle · one word, four constructsresidence time3 fields · 3 citationsinvariant · one construct, three systems

References

  1. Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2006). Drug–target residence time and its implications for lead optimization. Nature Reviews Drug Discovery, 5(9), 730-739. https://doi.org/10.1038/nrd2082

Cited on this page?

Confirm your construct, or correct us.

If your work is cited behind one of these entries, you know better than we do whether we captured the meaning right. Confirm it, suggest an edit, or dispute it, and your name goes on the entry as an author who has checked it, linked to your ORCID.

Claim your construct